Exploristics, the innovative data analysis company, is pleased to announce a new service that helps pharmaceutical and biotechnology companies identify and exploit new opportunities within their clinical development portfolios.

Exploristics has implemented tools that use existing clinical data to identify subgroups of patients with improved response to treatment. These tools can be applied at a study or portfolio level, and enable an informed and pragmatic approach to development decisions. To date, these tools have been used as a precursor to pharmacogenetics studies but can be applied to any subgroup analyses.

Visit our website or contact us for more information on this new service and our other services.